is all in $AAPL $TSLA and $PMCB
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cronin says Patriot One, too, is currently working with the Westgate Resort in Las Vegas to employ one of its first systems in the U.S., after demonstrating a trial of the technologies at the location earlier this year.
https://patriot1tech.com/news/las-vegas-shooting-security-experts-hotels-can-prevent-another-tragedy/
$PTOTF on Discovery Channel
thousands [of NDAs] are signed every day and 99.9% are just a useless piece of paper.
Curious for you to give an example of the 0.1% of useful NDAs.
https://www.forbes.com/sites/allbusiness/2016/03/10/the-key-elements-of-non-disclosure-agreements/#6f915d9a627d
As a publicly traded company there can be no NDA's in place for years that have anything to do with funding or partnerships.
Wow. Can you cite the SEC regulation that prohibits the normal, everyday act of signing an NDA?
DOLV. t trade already posting? Usually see them in the afternoon.
??????????????????
Those are called DKs, for "Don't Know".
In the morning you get a report of all your trades and when the other side of your trade doesn't report it, doesn't know the trade, you have to go to the primary market maker to resolve.
I kinda got the sense the Sheriff was voicing his frustrations. Surely the FBI has taken over every single aspect of this investigation by now and perhaps he doesn't believe they are focusing on that possibility.
And remember, it's not just "one man", it's "one 64-year old man".
They have the room service receipt from the other room that clearly indicates "2 guests" with food enough for two people. The number of guns is odd for one shooter and, thinking about his full arsenal which included shotguns, he had no shotguns on hand in that room. He also had a car with more guns and ammo and make-shift bomb material downstairs.
IMO if he had expected to die in a shootout in that room he would have brought one or more of his shotguns. Also, he only had one handgun.
You can imagine from this setup he planned to shoot the ARs from the windows and then vacate the room, armed only with the one concealed handgun, to get to his fallback weapons in the car.
He registered the room in his girlfriends name, and then wired her money. Was that intended as a diversion? As the son of an FBI's Most Wanted father, perhaps he indented to go on the run. If he had large amounts of cash in that room or in the car it would suggest that.
I think the Mandalay Bay security guard, Mr. Campos, is the hero that threw a monkey wrench in the shooter's original plan.
BNN's videos on $ACBFF
http://www.bnn.ca/related/tag?Tag=Aurora%20Cannabis
Note that Flash is required to view these videos.
Broker-Dealer short interest in $PMCB increased by 477.42% from Aug 31, 2017 to Sept. 15, 2017, from 14,000 shares on 8/31 to 80,839 shares on 9/15.
You have to go here http://otce.finra.org/ESI and enter "pmcb" to see the results. Other sites may claim to show you short interest, but this is actual data based on mandatory reports to FINRA from all members. What is a FINRA member? It's a broker-dealer. What's special about broker-dealers? They can do Naked Shorts. That is, they can sell stock without borrowing shares.
Data for Sept. 30 is due Oct 10th. I'm expecting to see another dramatic increase in naked short interest in $PMCB like the 477.42% increase we just saw.
Take a look just under the Intro on our page. You see a Quote box, a Chart box and a Community Sentiment box.
What is the Community Sentiment box? Well, it adds up the total number of bullish (positive) comments and compares that to the number of bearish (negative) comments and visually displays that in a bar graph. Dark green bars means everyone is bullish, while light green, white, and then red bars mean everyone is bearish.
Notice for $PMCB how the Community Sentiment has gone from steady green to light green to white on some days. Interesting stuff.
Short interest don't have to be closed out at the end of the month, but many broker-dealers that are open to day traders do encourage shorts to close so they don't have to bother reporting.
Really, truly, remarkable coincidence here that the whole "Kerr" incident happened on the day that short interests would have wanted to cover. If you recall, the "Kerr" incident caused people to sell 5 times the normal volume in shares in $PMCB.
If you find this suspicious and suspect something is amiss, please use the SEC Whistleblower tip system to let the SEC's new Cyber Unit know.
https://www.sec.gov/whistleblower/submit-a-tip
I did.
The SEC has a new Cyber Unit and one of the duties of the Cyber Unit is to monitor for:
"Market manipulation schemes involving false information spread through electronic and social media"
https://www.sec.gov/news/press-release/2017-176
Nice trade Musky!!!
You keep saying 20 year old tech and 5 year old tech.
The process since just 2015 is to make the encapsulated cells and then freeze them. It's a two year old process. Period.
Before 2015, the cells had to be manufactured and injected immediately. It's all there in black and white.
From 2015 to about to file a pivotal phase 2 trial for a biologic is great progress in my book.
I think Kerr had his social media accounts hacked. The statement about cellulose requiring a safety study was way too far fetched to be believable.
CARA. Doubled my money, twice.
for a 20 year old gimmick technology
Pretty amazing that so far in 2017 there are 10 scholarly articles, publications and patents with the three keywords "cellulose cell encapsulation".
https://scholar.google.com/scholar?as_ylo=2017&q=cell+encapsulation+cellulose
A read head scratcher. The FED has been announcing from the rooftops that interest rates are going up, likely three times, in 2018. Common sense would dictate an increase in fixed rate mortgages. Nope.
Bad sign for at least three reasons: real estate prices have risen so quickly that people don't have a choice but to get ARMs; homes are increasing being purchased by flippers or investors; and/or banks are pushing people into mortgages that are best for the banks, not for the consumers.
Five cases so far, out of millions of phones. This is a problem where the battery seems to expand after a long charge. No melting phones ala Samsung to date. Fingers crossed!
ADJUSTABLE RATE MORTGAGES JUMP FROM 15% TO 40% Q2 2017
https://www.thenorrisgroup.com/blog/news/adjustable-rate-mortgages-jump-15-40-q2-2017
here we go again...
I am by no means a pharma/biotech expert. Right now I own stock or options in the following:
AGN AXON AZN BLUE CARA EARS GSK JNJ NVO ONCE OTIC SGMO and $PMCB
And we have been in delay mode since this past February...the current pps reflects this...The silence has caused pps to fall
May 8, 2017
PharmaCyte Biotech Updates IND Submission Process in Interview with Facet Life Sciences
“Before the IND is filed, the following items must be available for inclusion:
(a) Documentation of preclinical work done on the cells.
(b) Toxicology studies.
(c) Documentation of preclinical work done on the capsules themselves.
(d) A wide array of CMC (Chemistry, Manufacturing and Controls) documentation that verifies that the final biologic product (the encapsulated cells) has been produced under current Good Manufacturing Practices (cGMP)-compliant conditions.
(e) Labeling for the final investigational biologic product.
(f) Previous evidence of human experience with the pancreas cancer therapy (low-dose ifosfamide plus Cell-in-a-Box® encapsulated genetically modified human cells).
(h) The Investigator’s Brochure.
(i) The Informed Consent Form
(j) The Case Report Form”
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, commented, “This year’s annual meeting of ASCO will be our most important as we work towards enrolling the first patient in our planned clinical trial in locally advanced pancreas cancer (LAPC). During this multi-day event, we will be hosting a special meeting of leading clinical oncologists who have expressed interest in participating in our clinical trial.
Commenting on the meeting, Mr. Waggoner said, “We were pleased to have had this unique opportunity to update the various stakeholders on the progress we have made in several aspects of our planned clinical trial. We are extremely grateful to the oncologists who attended the meeting, as well as the representatives from TD2 and Imaging Endpoints who participated in the meeting. We are particularly grateful to Dr. Matthias Löhr who travelled from Sweden to lead the discussion on the trial design and respond to questions posed by the oncologists.”
“Having won the 2017 Buzz of BIO 'Pipelines of Promise' award, we have been given the opportunity to build upon that by presenting PharmaCyte’s therapy for pancreatic cancer to thousands of industry leaders who will attend this year’s convention.
“We are also being interviewed by Mike Huckman, a former pharmaceuticals reporter for CNBC, to showcase our pancreatic cancer therapy. And we have meetings scheduled with potential strategic partners, biotech companies that have expressed an interest in PharmaCyte and numerous other industry thought leaders who have reached out to us to learn more about PharmaCyte.”
Dr. Sher is a Professor of Clinical Surgery and Director of Clinical Research in the Division of Hepatobiliary and Pancreatic Surgery and Abdominal Organ Transplantation at the University of Southern California’s (USC) Keck School of Medicine. Dr. Sher is also the Chief of the Division of Clinical Research for the Department of Surgery where she oversees the implementation and conduct of clinical trials for the entire department, averaging between 50 and 70 studies at all times. She is also the Vice Chair of the USC Institutional Review Board.
Senator Feinstein introduces "Automatic Gunfire Prevention Act"
‘‘(v)(1) Except as provided in paragraph (2), on and
4 after the date that is 180 days after the date of enactment
5 of this subsection, it shall be unlawful for any person to
6 import, sell, manufacture, transfer, or possess, in or af-
7 fecting interstate or foreign commerce, a trigger crank,
8 a bump-fire device, or any part, combination of parts,
9 component, device, attachment, or accessory that is de-
10 signed or functions to accelerate the rate of fire of a semi-
11 automatic rifle but not convert the semiautomatic rifle
12 into a machinegun.
$PMCB DD
Know What You Own!
Factual Posts:
Medical and scientific personnel currently associated with $PMCB
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134711479
Principal Investigator will be Dr. Hidalgo, MD, PhD
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134723048
Master Cell Bank being produced by Eurofins
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134794043
Austrianova's IP
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134787469
$PMCB's new corporate law firm
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134622365
$PMCB has four institutional investors with small, "placeholder" positions
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134474894
Recent $PMCB Events
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134528572
Speculative Posts:
Why would a large pharma company want anything to do with $PMCB?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134833898
Regarding the S-3 law firm
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134711413
Pattern related to S-3 Filings and partnerships
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134711743
My last firm was hit by a targeted Email Storm. It's like a Denial of Service attack, but with massive amounts of spam email with huge attachments and lots of virus just pounding you ever second. It just overwhelms the email servers. My email was down for 3 days, and that's with a team of 20 people in IT. If such a thing were to happen with PMCB their email might be down for a long time.
In any event, the answers regarding the timeline have been posted on FB.
I really don't understand what sort of biotechs people are used to dealing with if then expect bombarding IR is going to get data released sooner. In the history of biotech investing, has that ever worked anywhere?!?
If the PMCB timeline doesn't fit your investment objectives, move on.
This is a list of announced timelines for biotech companies:
https://www.biopharmcatalyst.com/calendars/fda-calendar There you go, more than a dozen companies with news in the coming weeks.
How many different ways does PMCB need to say the IND timeline is out of their hands as they await for Eurofins and Austrianova to do purity testing, etc. etc. etc.???
4chan is barely a step above the dark web. Absolutely subhuman.
However, this 4chan warning was on September 11, 2017. Now it turns out that Stephen Paddock may have first targeted the Life is Beautiful Festival on September 22-24!!!
That is quite a coincidence.
http://nypost.com/2017/10/03/vegas-shooter-may-have-been-targeting-another-music-festival/
and right on cue as per 4Chan "John":
Wynn Hotels adds metal detectors:
http://www.dailymail.co.uk/news/article-4943020/Las-Vegas-rampage-prompt-casinos-think-security-experts.html
HuffPo: Do all US Hotels need metal detectors?
http://www.huffingtonpost.com/entry/do-us-hotels-need-metal-detectors_us_59d281d1e4b092b22a8e388f
That is a very remarkable coincidence.
Congratulations on your win!
$EARS has catalysts coming in 2017 Q4 and 2018 Q1 and Q4:
Phase 3 AM-111 HEALOS - for Acute inner ear hearing loss. Completion of enrollment announced June 5, 2017. Data due 4Q 2017.
Phase 1 AM-125, an intranasal formulation of betahistine for the treatment of Meniere's disease and other vestibular disorders. Goal is to start Phase 1 in Q4 2017.
Phase 3 AM-101 Keyzilen TACTT3 - for Acute inner ear tinnitus. Enrollment resumption announced January 26, 2017 with top-line data 1Q 2018.
Phase 3 AM-111 ASSENT - for Acute inner ear hearing loss. Data due 2H 2018.
$EARS needs some good data on HEALOS! They are clearly hedging with AM-125 in the same quarter. The good news is they are a penny stock bio with THREE Phase 3 trials underway. High risk, high reward.
Me too! And getting the new Watch 3 soon afterwards!
This is an interesting video. Cabby was just recording when the shooting started, she seems to have been on the other side of the Mandalay Bay BSing with other cab drivers.
The first shots are echoed I believe. Then the next volley seems farther away, then the next directly overhead. From this video you can understand why people were calling 911 with reports of multiple shooters.
Cabby picks up some concert goers later so you hear their accounts. Wild.
https://twitter.com/MonicaNumidia/status/915291928467578883
In case you want
DD Support Board, Fraud and Conspiracy Theory Research Team
take a look at this, originally posted on 4chan on September 10/11 2017:
On 9/10, an anonymous user on /pol/ predicted a shooting in Las Vegas and discussed the reasons behind it. #LasVagasShooting pic.twitter.com/p9zuUgZGAH
— Mike Coudrey (@MichaelCoudrey) October 3, 2017
Wow. Just can't wait to try it. But what does it... do?
The use of cannabis as a medicine by ancient Chinese was reported in the world's oldest pharmacopoeia, the pen-ts'ao ching which was compiled in the first century of this Era, but based on oral traditions passed down from the time of Emperor Shen-Nung, who lived during the years 2.700 B.C. Indications for the use of cannabis included: rheumatic pain, intestinal constipation, disorders of the female reproductive system, malaria, and others. In the beginning of the Christian Era, Hua T'o, the founder of Chinese surgery (A.D. 110 – 207), used a compound of the plant, taken with wine, to anesthetize patients during surgical operations.
SEC Charges Penny-Stock Operators in Push to Crack Down on Repeat Offenders
FOR IMMEDIATE RELEASE
2017-188
Washington D.C., Oct. 3, 2017—
The Securities and Exchange Commission today charged two individuals with defrauding investors in penny stock companies that claimed to have valuable patents. One of those charged had been barred from the penny stock business based on his role in another securities scheme and neither he nor his companies had ever been issued any patents by the U.S. Patent and Trademark Office, the SEC alleged.
The SEC’s complaint, filed in U.S. District Court for the Southern District of Florida, charged Rockey “Roc” G. Hatfield, of Safety Harbor, Florida, Steve E. Lovern, of Atlanta, Belize-based N1 Technologies Inc., and Wyoming-based NanoSave Technologies Inc. Hatfield is a repeat offender whose prior securities schemes resulted in a criminal conviction, injunctions, a contempt of court finding, and broker-dealer, investment adviser, and penny-stock bars. The SEC’s complaint alleges Hatfield controlled the two companies but concealed his role in them by having his wife and Lovern named as corporate officers and directors.
The U.S. Attorney’s Office for the Southern District of Florida today filed related criminal charges against Hatfield, Lovern, and others, and the SEC announced a trading suspension in NanoSave Technologies (NNSV).
According to the SEC’s complaint, the defendants hired unregistered brokers to cold call investors and pitch investments in “patent units,” using scripts written by Hatfield, including one that falsely claimed N1 Technologies had patented a cure for staph infections. Investors were told that purchasing an $80,000 unit could yield as much as $1 million based on sales of similar patents, the SEC alleged. The SEC alleged that although investors were told that their money would help fund further research and development, the defendants used most of it for personal expenditures and to pay sales commissions of up to 40 percent.
“As alleged in our complaint, Hatfield is a recidivist who fraudulently raised money by selling investors interests in non-existent patents,” said Eric I. Bustillo, Director of the SEC’s Miami Regional Office. “This action is part of the Miami Regional Office’s Recidivist Initiative and the Commission’s efforts to pursue recidivist violators and hold them accountable.”
The SEC is seeking return of the defendants’ allegedly ill-gotten gains, with interest, a civil monetary penalty, a court injunction, and other relief.
The SEC’s investigation, which is continuing, is being conducted by Jordan A. Cortez and Mark Dee in the Miami Regional Office. The case is being supervised by Eric. R. Busto and the SEC’s litigation is being led by Alejandro Soto. The SEC appreciates the assistance of the U.S. Attorney’s Office for the Southern District of Florida, the Federal Bureau of Investigation’s Miami Field Office, and the Financial Industry Regulatory Authority.
###
https://www.sec.gov/news/press-release/2017-188
TV and radio mostly.
There was this interesting piece in Daily Mail: http://www.dailymail.co.uk/news/article-4945322/Vet-wants-know-cops-took-long-stop-shooter.html
Yes, it wasn't 72 minutes of constant gunfire. No, there weren't multiple shooters. I wrote "2 of the shooters guns" and that should have been "2 of the shooter's guns".
I'm merely suggesting that hotel staff should perhaps be trained to pick up on unusual guests.
Yeah, that would be impossible. Hum, is that guy all sweaty and nervous because he:
a) just cheated on his wife
b) just lost $50K on blackjack
c) just bought cannabis to use in his room
e) has guns in his room
I was the only guy with a Corgi to walk around the UN. There is (was) a dog run just south of the UN.
Everyone loved that dog, she was always so happy. : ) Tudor City was really nice too. Very, very safe part of the city with those Cop-in-a-Box things.
It was nice to see defensive, cold, untrusting, weary, jaded New Yorkers smile and just spontaneously pet my dog. They totally ignored me of course. Palm is (was?) right around the corner too. Capital Grill on 42nd had a killer steak salad.
Great find Wolfy! I skipped around in the video, it is very granular. Q&A starts around 1 hour 5, if you want to hear how they handle random questions. A+++ in my book.
I recall purchasing luggage at Century 21 and rolling them home, right down Broad St. in front of the NYSE. I could feel the scopes and paint from lasers on my body. I know what you mean.
Ah, Century 21. Only true New Yorkers know about that retail gem!!!
Yeah, I'd always walk my dog near the UN and I always felt like scopes were directed at me. Weird what you get used to living in such a big city.
The 3-day power outage of 2003 in Manhattan was so bad. My dog nearly died from the heat.
Ex-CEO Smith of $EFX today:
"In January 2018, Equifax will offer a new, free app to freeze your credit report via $AAPL."
He said "turret" but it sounded like "turd", so whoever edited the video threw that in for humor?
Confirmed by FBI (as per NPR news radio) 2 of the shooters guns had the "bump fire" stock and his arsenal did include some fully automatic weapons.
A 64-year old who was able to shoot for 74 minutes. I wonder if they found any drugs in his system.
World Investor Week Brings Together Securities Regulators on Six Continents to Promote Investor Education and Protection
Joint Investor Bulletin Issued With CFTC, FINRA and NASAA on Tips for Smart Investing
FOR IMMEDIATE RELEASE
2017-187
Washington D.C., Oct. 2, 2017—
The Securities and Exchange Commission, along with the U.S. Commodity Futures Trading Commission (CFTC) and the Financial Industry Regulatory Authority (FINRA), is leading efforts in the U.S. to raise awareness about the importance of investor education and protection as part of a global effort. World Investor Week, promoted by the International Organization of Securities Commissions (IOSCO), takes place October 2-8, 2017, marking the first time securities regulators on six continents are joining together to highlight what it means to be a smart investor as well as ways to avoid fraud.
During World Investor Week, SEC staff is participating in events around the country amplifying vital messages to investors, such as:
Going to Investor.gov before investing
Doing a background check on an investment professional
Conducting research on products before investing
Knowing the risks and fees associated with all investments
Recognizing the importance of diversification and the power of compound interest
Setting investment goals
Learning how to avoid fraud
In addition, the SEC’s Office of Investor Education and Advocacy today issued a joint investor bulletin with the CFTC, FINRA, and the North American Securities Administrators Association (NASAA) to promote these key messages.
“The best way to protect Main Street investors from becoming victims of fraud is to educate them. We want investors to ask smart questions. It’s good for them and it’s good for our markets,” said SEC Chairman Jay Clayton. “The SEC remains committed to helping all Americans reach their investment goals and protect their hard-earned money, and that’s why events like World Investor Week and the continued efforts of the Office of Investor Education and Advocacy are instrumental to the mission of this agency.”
“I see first-hand the positive impact of our investor education efforts, whether it’s our outreach team conducting in-person events, online resources on Investor.gov and public service campaigns or our assistance team that handles investor complaints and solves problems on a daily basis,” said Lori Schock, Director of the SEC’s Office of Investor Education and Advocacy. “This week-long global effort reinforces the importance of what we and others do every day on behalf of America’s investors.”
SEC staff outreach events include: an information session with seniors answering questions on investing, retirement and ways to protect against fraud, a Twitter chat about the various issues surrounding investing with robo-advisers, a Thrift Savings Plan (TSP) program for federal employees covering TSP distribution options, withdrawals, fees and how to avoid scams, and numerous saving and investing presentations for students and military service members.
For a list of other SEC outreach activities or to learn more about this global effort to promote investor education and protection and how investors can get involved, visit Investor.gov.
###
https://www.sec.gov/news/press-release/2017-187
Sticky worth?
Hell of a closing rally.
Looks like Bears gave up around 2 p.m. and the Bulls came back for a nice recovery.
BarChart says $PMCB is approaching Oversold territory. Should be an interesting week.
https://www.barchart.com/stocks/quotes/PMCB/overview
Go $PMCB longs!
Yes, Janice, he was quite old to conduct a mass shooting.
Several people at my local range who are AR enthusiasts said- after watching the various video recordings- that he likely had a "GAT Crank" on his rifles. This is based on the very consistent rate of fire. I'm not an AR person so I have no idea, but that is what multiple people said.
How did he get 18 weapons into the hotel?
In a Louis Vuitton trunk. Not one eyebrow would be raised.
Yes, absolutely. Phase 2b is what the FDA said in the pre-IND meeting.
Info on how a phase 2b is different from a phase 2 and how the "pivot" works:
"Using decision theory, Gilbert outlines how to effectively surmise one of five decisions at the end of a phase 2B trial: (i) treatment is harmful, (ii) treatment is useless, (iii) treatment is plausible and a phase 3 trial should be conducted, (iv) treatment meets phase 3 criteria for efficacy, or (v) treatment meets criteria for efficacy from two phase 3 trials.
The decision theory framework is the mathematical formula that allows the study team to place weights as to the importance of each of the above five concepts in determining a study outcome while still arriving at a single decision on the basis of the size of the effect of the treatment in the study. This makes decision theory no more difficult to interpret than interpreting a P value above or below 0.05. Using this study design framework, Gilbert theorizes that moving to a phase 3 study from a phase 2 study is only warranted when the pre-test plausibility of treatment success is extremely high. This work establishes the role that phase 2B studies can play in moving more treatments from the bench to final clinical testing in humans and shows how decision theory can be used to expand the considerations included in a studies design."
from Phase 2B Clinical Trials—A Useful Interim Step to a Phase 3 Clinical Trial
http://stm.sciencemag.org/content/2/31/31ec76